Michael Militello

1.1k total citations
37 papers, 745 citations indexed

About

Michael Militello is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Internal Medicine. According to data from OpenAlex, Michael Militello has authored 37 papers receiving a total of 745 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Cardiology and Cardiovascular Medicine, 13 papers in Surgery and 9 papers in Internal Medicine. Recurrent topics in Michael Militello's work include Venous Thromboembolism Diagnosis and Management (9 papers), Heparin-Induced Thrombocytopenia and Thrombosis (7 papers) and Atrial Fibrillation Management and Outcomes (7 papers). Michael Militello is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (9 papers), Heparin-Induced Thrombocytopenia and Thrombosis (7 papers) and Atrial Fibrillation Management and Outcomes (7 papers). Michael Militello collaborates with scholars based in United States. Michael Militello's co-authors include John R. Bartholomew, Marcelo Gomes, Mary Beth Bobek, Siddharth Dugar, Gretchen L. Sacha, Keith R. McCrae, Simon Mucha, Herbert D. Aronow, Gian M. Novaro and Mario J. García and has published in prestigious journals such as Blood, Journal of the American College of Cardiology and CHEST Journal.

In The Last Decade

Michael Militello

36 papers receiving 723 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Militello United States 15 293 266 200 125 98 37 745
Payal Patel United States 10 118 0.4× 126 0.5× 190 0.9× 158 1.3× 120 1.2× 22 779
Donald Schreiber United States 14 661 2.3× 289 1.1× 549 2.7× 44 0.4× 94 1.0× 26 1.2k
Dieter Conen Switzerland 12 204 0.7× 174 0.7× 113 0.6× 27 0.2× 144 1.5× 24 658
Alberto Pagnamenta Switzerland 17 262 0.9× 101 0.4× 54 0.3× 52 0.4× 52 0.5× 50 682
Laura Young United States 12 556 1.9× 253 1.0× 467 2.3× 15 0.1× 61 0.6× 44 874
Daniel Neves Forte Brazil 12 97 0.3× 152 0.6× 32 0.2× 34 0.3× 26 0.3× 39 677
Alicia Lorenzo Spain 14 162 0.6× 69 0.3× 224 1.1× 25 0.2× 42 0.4× 44 645
Wieneke M. Michels Netherlands 15 227 0.8× 168 0.6× 31 0.2× 15 0.1× 121 1.2× 28 1.0k
J. Bouget France 15 77 0.3× 52 0.2× 32 0.2× 134 1.1× 43 0.4× 47 578
Gualberto Gussoni Italy 14 174 0.6× 62 0.2× 55 0.3× 41 0.3× 19 0.2× 42 530

Countries citing papers authored by Michael Militello

Since Specialization
Citations

This map shows the geographic impact of Michael Militello's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Militello with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Militello more than expected).

Fields of papers citing papers by Michael Militello

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Militello. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Militello. The network helps show where Michael Militello may publish in the future.

Co-authorship network of co-authors of Michael Militello

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Militello. A scholar is included among the top collaborators of Michael Militello based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Militello. Michael Militello is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Militello, Michael, et al.. (2024). Digoxin is still useful, but is still causing toxicity. Cleveland Clinic Journal of Medicine. 91(8). 489–499. 2 indexed citations
2.
Militello, Michael, et al.. (2023). Evaluation of Response to High-Dose Intravenous Vitamin K Administration. Annals of Pharmacotherapy. 57(10). 1178–1184. 2 indexed citations
3.
Mucha, Simon, Siddharth Dugar, Keith R. McCrae, et al.. (2020). Coagulopathy in COVID-19: Manifestations and management. Cleveland Clinic Journal of Medicine. 87(8). 461–468. 72 indexed citations
4.
Mucha, Simon, Siddharth Dugar, Keith R. McCrae, et al.. (2020). Update to coagulopathy in COVID-19: Manifestations and management. Cleveland Clinic Journal of Medicine. 5 indexed citations
5.
Bauer, Seth R., Stephanie Bass, Michael Militello, et al.. (2020). Effectiveness and Safety of Twice Daily Versus Thrice Daily Subcutaneous Unfractionated Heparin for Venous Thromboembolism Prophylaxis at a Tertiary Medical Center. Journal of Pharmacy Practice. 35(2). 190–196. 2 indexed citations
6.
Bauer, Seth R., Stephanie Bass, Heather Torbic, et al.. (2019). Effectiveness of venous thromboembolism prophylaxis in patients with liver disease. World Journal of Hepatology. 11(4). 379–390. 8 indexed citations
7.
Hutt, Erika, Michael Militello, & Marcelo Gomes. (2019). Anti-Xa assays: What is their role today in antithrombotic therapy?. Cleveland Clinic Journal of Medicine. 86(6). 417–425. 26 indexed citations
8.
Haddadin, Ihab, Natalie Evans, Marcelo Gomes, et al.. (2018). A pulmonary embolism response team (PERT) approach: initial experience from the Cleveland Clinic. Journal of Thrombosis and Thrombolysis. 46(2). 186–192. 40 indexed citations
9.
Chen, Kevin, et al.. (2017). Teaching an Old Dog New Tricks: Colchicine in Cardiovascular Medicine. American Journal of Cardiovascular Drugs. 17(5). 347–360. 19 indexed citations
10.
Jacobi, Judith, Shaunta’ M. Ray, Elizabeth Dodds Ashley, et al.. (2016). Impact of the Pharmacy Practice Model Initiative on Clinical Pharmacy Specialist Practice. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 36(5). e40–9. 24 indexed citations
11.
Kantorovich, Alexander, et al.. (2015). Low-Dose 3-Factor Prothrombin Complex Concentrate for Warfarin Reversal Prior to Heart Transplant. Annals of Pharmacotherapy. 49(8). 876–882. 14 indexed citations
12.
Kantorovich, Alexander, et al.. (2015). Comparison of Anticoagulation Strategies After Left Ventricular Assist Device Implantation. ASAIO Journal. 62(2). 123–127. 8 indexed citations
13.
Joseph, Lee, Ana I. Casanegra, Martin Smith, et al.. (2014). Bivalirudin for the treatment of patients with confirmed or suspected heparin‐induced thrombocytopenia. Journal of Thrombosis and Haemostasis. 12(7). 1044–1053. 47 indexed citations
14.
Lawrence, David, Walid Saliba, Mandeep Bhargava, et al.. (2014). DOFETILIDE LONG-TERM EFFICACY DESPITE INABILITY TO CONVERT TO SINUS RHYTHM DURING ADMISSION FOR DRUG-INITIATION. Journal of the American College of Cardiology. 63(12). A421–A421. 1 indexed citations
15.
Lawrence, David, Mandeep Bhargava, Michael Militello, et al.. (2014). SAFETY OF ORAL DOFETILIDE LOADING FOR RHYTHM CONTROL OF ATRIAL ARRHYTHMIAS. Journal of the American College of Cardiology. 63(12). A435–A435. 1 indexed citations
16.
Rassi, Andrew N., Eugene H. Blackstone, Michael Militello, et al.. (2012). Safety of “Bridging” With Eptifibatide for Patients With Coronary Stents Before Cardiac and Non-Cardiac Surgery. The American Journal of Cardiology. 110(4). 485–490. 23 indexed citations
17.
Anwaruddin, Saif, Arman T. Askari, Penny L. Houghtaling, et al.. (2009). Characterization of Post-Operative Risk Associated With Prior Drug-Eluting Stent Use. JACC: Cardiovascular Interventions. 2(6). 542–549. 59 indexed citations
18.
Dager, William E., et al.. (2007). Heparin‐Induced Thrombocytopenia: Treatment Options and Special Considerations. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 27(4). 564–587. 41 indexed citations
19.
20.
Tang, W.H. Wilson, Michael Militello, & Gary S. Francis. (2003). In heart failure, all beta-blockers are not necessarily equal.. Cleveland Clinic Journal of Medicine. 70(12). 1081–1087. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Payal Patel Breakdown of academic impact, for papers by Donald Schreiber Breakdown of academic impact, for papers by Dieter Conen Breakdown of academic impact, for papers by Alberto Pagnamenta Breakdown of academic impact, for papers by Laura Young Breakdown of academic impact, for papers by Daniel Neves Forte Breakdown of academic impact, for papers by Alicia Lorenzo Breakdown of academic impact, for papers by Wieneke M. Michels Breakdown of academic impact, for papers by J. Bouget Breakdown of academic impact, for papers by Gualberto Gussoni
Rankless by CCL
2026